Nipocalimab reduces Sjögren disease activity in phase II trial
Nature Reviews Rheumatology, Published online: 24 November 2025; doi:10.1038/s41584-025-01334-6 The results of the phase II DAHLIAS trial support the development […]
Nature Reviews Rheumatology, Published online: 24 November 2025; doi:10.1038/s41584-025-01334-6 The results of the phase II DAHLIAS trial support the development […]
Nature Reviews Rheumatology, Published online: 24 November 2025; doi:10.1038/s41584-025-01326-6 This Review explores the complex relationship between obesity and psoriatic disease.
Nature Reviews Rheumatology, Published online: 19 November 2025; doi:10.1038/s41584-025-01321-x Childhood-onset SLE is characterized by high disease activity, severe organ damage
Nature Reviews Rheumatology, Published online: 18 November 2025; doi:10.1038/s41584-025-01330-w Findings reveal that inhibiting cytosolic phospholipase A2 in chondrocytes could be
Nature Reviews Rheumatology, Published online: 17 November 2025; doi:10.1038/s41584-025-01331-9 Author Correction: Occupational dust and chemical exposures and the development of
Nature Reviews Rheumatology, Published online: 13 November 2025; doi:10.1038/s41584-025-01323-9 The factors and mechanisms that regulate osteoclast-induced inflammatory bone loss are
Nature Reviews Rheumatology, Published online: 07 November 2025; doi:10.1038/s41584-025-01325-7 A new population-based study suggests that sodium–glucose cotransporter-2 (SGLT2) inhibitors —
Nature Reviews Rheumatology, Published online: 07 November 2025; doi:10.1038/s41584-025-01318-6 This Review discusses latest advances in the field of cutaneous lupus,
Nature Reviews Rheumatology, Published online: 06 November 2025; doi:10.1038/s41584-025-01309-7 This Review article provides an update on the pathophysiology, diagnosis and
Nature Reviews Rheumatology, Published online: 30 October 2025; doi:10.1038/s41584-025-01324-8 In a phase III placebo-controlled trial, the addition of telitacicept to
Nature Reviews Rheumatology, Published online: 30 October 2025; doi:10.1038/s41584-025-01320-y Biallelic loss-of-function mutations in PLD4, as identified in five patients with
Nature Reviews Rheumatology, Published online: 23 October 2025; doi:10.1038/s41584-025-01311-z Progress has been astonishing, but the need for personalized care can
Nature Reviews Rheumatology, Published online: 16 October 2025; doi:10.1038/s41584-025-01316-8 Potential benefit of anticoagulation in Behçet syndrome
Nature Reviews Rheumatology, Published online: 16 October 2025; doi:10.1038/s41584-025-01317-7 Reply to ‘Potential benefit of anticoagulation in Behçet syndrome’
Nature Reviews Rheumatology, Published online: 16 October 2025; doi:10.1038/s41584-025-01306-w ANCA-associated vasculitis (AAV) includes three disease subtypes with partly overlapping clinical
Nature Reviews Rheumatology, Published online: 13 October 2025; doi:10.1038/s41584-025-01310-0 Generative artificial intelligence promises to reshape clinical care in rheumatology by
Nature Reviews Rheumatology, Published online: 03 October 2025; doi:10.1038/s41584-025-01305-x This Perspective article discusses the stratification of patients with knee osteoarthritis
Nature Reviews Rheumatology, Published online: 02 October 2025; doi:10.1038/s41584-025-01315-9 Findings demonstrate that STING mediates necroptosis in the context of autoinflammatory
Nature Reviews Rheumatology, Published online: 01 October 2025; doi:10.1038/s41584-025-01312-y Although DADA2 is typically described as an autosomal recessive disease, it
Nature Reviews Rheumatology, Published online: 01 October 2025; doi:10.1038/s41584-025-01313-x Infused lipid nanoparticles were successfully used to generate CAR-T cells in
Nature Reviews Rheumatology, Published online: 01 October 2025; doi:10.1038/s41584-025-01302-0 Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory
Nature Reviews Rheumatology, Published online: 30 September 2025; doi:10.1038/s41584-025-01314-w Author Correction: Parathyroid hormone receptor agonists in the management of osteoporosis
Nature Reviews Rheumatology, Published online: 29 September 2025; doi:10.1038/s41584-025-01308-8 Both rheumatology and the publishing environment have seen tremendous changes over
Nature Reviews Rheumatology, Published online: 25 September 2025; doi:10.1038/s41584-025-01304-y In the past two decades the field of hand osteoarthritis (OA)
Nature Reviews Rheumatology, Published online: 23 September 2025; doi:10.1038/s41584-025-01307-9 The collective priorities of the rheumatology field represent the lived experience,
Nature Reviews Rheumatology, Published online: 15 September 2025; doi:10.1038/s41584-025-01286-x This article provides a comprehensive overview of the epidemiology of spondyloarthritis
Nature Reviews Rheumatology, Published online: 09 September 2025; doi:10.1038/s41584-025-01298-7 Reply to ‘Inborn errors of immunity and AAV: a complex picture’